Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2010, Vol. 30 Issue (09): 19-23    DOI: Q78
    
Genetic Stability and Titer Determination of Recombinant Adenovirus Expressing HA Gene of Strain H5N1 of Avian Influenza Virus
WANG Qing1,HU Jian-he1,XU Yan-zhao2
1.Henan Institute of Science and Technology, Xinxiang 453003,China
2.Chinese Academy of Agricultural Sciences, Shanghai Veterinary Institute, Shanghai 200241,China
Download: HTML   PDF(1151KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

The focus is to evaluate the genetic stability and titer determination of the recombinant adenovirus (pAd-H5) expressing HA gene of H5N1 Avian Influenza virus (AIV). The recombinant adenovirus pAd-H5 had been serially passaged for 20 passages in 293 cell line. The passages of 5,10,15 and 20 were chosen to be identified by PCR and sequence; Using GFP rapid monitoring method to test the viral titer of pAd-H5, passage 20. Furthermore, the analysis supported that HA gene was amplified correctly, without any changes on the nucleotide in passages of 5, 10 and 15. While there was only one point mutation on HA gene (417 A→G) in passage 20, but this point mutation did not lead to amino acid changes (samesense mutation). The titer of pAdH5 in 293 cell line identified by GFP rapid monitoring method was 108.75pfu/0.1ml. All the results showed that the pAd-H5 has good genetic stability within 20 passages, and the titer was relativly high.



Key wordsAvian Influenza virus (AIV)      Recombinant adenovirus (pAd)      Genetic stability      Titer determination     
Received: 22 February 2010      Published: 25 August 2010
Cite this article:

WANG Jing, HU Jian-He, XU Pan-Shao. Genetic Stability and Titer Determination of Recombinant Adenovirus Expressing HA Gene of Strain H5N1 of Avian Influenza Virus. China Biotechnology, 2010, 30(09): 19-23.

URL:

https://manu60.magtech.com.cn/biotech/Q78     OR     https://manu60.magtech.com.cn/biotech/Y2010/V30/I09/19

[1] 于康震, 付朝阳, 崔尚金, 等. 我国禽流感防制研究进展. 中国兽医学报, 2001, 21(1): 103106. Yu K Z, Fu C Y, Chui S J, et al. Chinese Journal of Veterinary Science, 2001, 21(1): 103106. 
[2] Yu H, Shu Y, Hu S, et al. The first confirmed human case of avian influenza A (H5N1) in Mainland China. Lancet, 2006, 367 (9504) :84. 
[3] 陈全姣, 金梅林, 陈焕春. 禽流感疫苗研究进展. 中国生物工程杂志, 2004,24(4):3438. Chen Q J, Jin M L, Chen H C. China Biotechnology, 2004,24(4):3438. 
[4] 王海燕, 于长青, 祝之明. 供转染的截短型PDGF2α受体高滴度腺病毒的制备及作用分析. 免疫学杂志, 2002, 4(18):308311. Wan H Y, Yu C Q, Zhu Z M. Immunological Journal, 2002, 4(18):308311. 
[5] 中国兽药典委员会. 中华人民共和国兽药典. 北京: 农业出版社, 1990. 12221251. Commission of Chinese Veterinary Pharmacopoeia. Chinese Pharmacopoeia. Beijing: China Agricultural Press, 1990.12221251. 
[6] 王明俊. 兽医生物制品学. 北京: 中国农业出版社, 1996.8088. Wan M J. Veterinary biological products. Beijing: China Agricultural Press, 1996.8088. 
[7] 张浩, 郭抗抗, 张彦明, 等. 共表达猪瘟病毒E0、E2基因重组鸡痘病毒的遗传稳定性. 西北农林科技大学学报(自然科学版) , 2008, 36(8) :3640. Zhang H, Guo K K, Zhang Y M, et al. Journal of Northwest A&F University(Natural Science Edition), 2008, 36(8) :3640. 
[8] 江千里, 王健民, 温丽敏, 等. 批量快速测定法测定标志基因为GFP的重组病毒滴度. 第二军医大学学报, 2002, 23(9):10341035. Jiang Q L, Wan J M, Wen L M, et al. Academic Journal of Second Military Medical University, 2002,23(9):10341035. 
[9] 乔传玲, 常洪涛, 于康震, 等. 共表达禽流感病毒HA和NA基因重组禽痘病毒的遗传稳定性. 微生物学报, 2004, 5(44): 686688. Qiao C L, Chang H T, Yu K Z, et al. Acta Microbiologica Sinica, 2004, 5(44): 686688. 
[10] 贾红玲, 苏艳, 吴润. 禽流感病毒血凝素保守氨基酸对其受体结合位点的影 响. 中国预防兽医学报, 2008, 30 (7): 500504. Jia H L, Su Y, Wu R. Chinese Journal of Preventive Veterinary Medicine, 2008, 30 (7): 500504. 
[11] 殷震, 刘景华. 动物病毒学. 第2版.北京: 科学出版社, 1997.708709. Yin Z, Liu J H. Animal Virology. 2nd. Beijing: Science Press, 1997.708709. 
[12] Smiley J R, Jackwood D J. Genetic stability of the VP2 hypervariable region of four infectious bursal disease virus isolates after serial passage in specific pathogen free chicken embryos. Avian Dis, 2001, 45 (1):18. 
[13] 冀德君, 彭大新, 刘红旗, 等. 表达H9亚型禽流感病毒HA基因重组鸡痘病毒疫苗的遗传稳定性. 中国兽医学报, 2003, 4(23): 347349. Ji D J, Peng D X, Liu H Q, et al. Chinese Journal of Preventive Medicine, 2003, 4(23): 347349. 
[14] 李培建, 李兵仓. 一种重组腺病毒载体的扩增、纯化和病毒滴度检测方法. 中华神经医学杂志, 2002, 1(1):5255. Li PJ, Li B C. Chinese Journal of Neuromedicine, 2002, 1(1):5255. 
[15] 周文泉, 闵志廉, 李莉, 等. 重组腺病毒Adp16的扩增及病毒滴度检测. 医学研究生学报, 2001, 1(14): 4446. Zhou W Q, Min Z L, Li L, et al. Journal of Medical Postgraduates, 2001, 1(14): 4446.

[1] ZHU Yi-long, LI Chang, GUO Yan, LIU Cun-xia, DU Shou-wen, WANG Mao-peng, JIN Ning-yi. Construction and Selection of the Recombinant Fowlpox Expressing HIV-1 gag[J]. China Biotechnology, 2014, 34(1): 57-63.
[2] . Construction of Recombinant Marek's Disease Virus Expressing M2 Gene of Avian Influenza Virus[J]. China Biotechnology, 2007, 27(9): 24-30.